Winslow Evans & Crocker Inc. lessened its stake in shares of Colgate-Palmolive (NYSE:CL) by 6.1% during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 30,646 shares of the company’s stock after selling 1,999 shares during the period. Colgate-Palmolive makes up approximately 0.7% of Winslow Evans & Crocker Inc.’s holdings, making the stock its 28th largest holding. Winslow Evans & Crocker Inc.’s holdings in Colgate-Palmolive were worth $2,233,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in CL. Transamerica Financial Advisors Inc. increased its stake in Colgate-Palmolive by 0.3% in the first quarter. Transamerica Financial Advisors Inc. now owns 25,183 shares of the company’s stock worth $1,844,000 after purchasing an additional 67 shares during the period. Ronald Blue & Co. LLC increased its stake in Colgate-Palmolive by 1.1% in the first quarter. Ronald Blue & Co. LLC now owns 3,501 shares of the company’s stock worth $256,000 after purchasing an additional 37 shares during the period. USS Investment Management Ltd increased its stake in Colgate-Palmolive by 1.6% in the first quarter. USS Investment Management Ltd now owns 683,600 shares of the company’s stock worth $50,036,000 after purchasing an additional 10,600 shares during the period. Stifel Financial Corp increased its stake in Colgate-Palmolive by 0.8% in the first quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock worth $22,250,000 after purchasing an additional 2,360 shares during the period. Finally, ARS Investment Partners LLC increased its stake in Colgate-Palmolive by 0.5% in the first quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock worth $2,601,000 after purchasing an additional 175 shares during the period. Institutional investors own 72.96% of the company’s stock.

In related news, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction dated Thursday, November 9th. The stock was sold at an average price of $73.07, for a total transaction of $730,700.00. Following the sale, the insider now owns 60,528 shares of the company’s stock, valued at $4,422,780.96. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Jennifer Daniels sold 7,375 shares of the firm’s stock in a transaction dated Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the sale, the insider now directly owns 38,691 shares in the company, valued at approximately $2,831,407.38. The disclosure for this sale can be found here. Insiders have sold a total of 181,048 shares of company stock worth $13,168,995 in the last three months. Corporate insiders own 1.02% of the company’s stock.

A number of analysts have weighed in on CL shares. Jefferies Group reiterated a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research note on Thursday, August 24th. Macquarie started coverage on Colgate-Palmolive in a research note on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price on the stock. Zacks Investment Research lowered Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Wednesday, September 20th. Morgan Stanley upgraded Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $75.00 to $84.00 in a research note on Monday, September 25th. Finally, Royal Bank of Canada reiterated a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Two equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $76.04.

Colgate-Palmolive (NYSE:CL) opened at $74.05 on Friday. Colgate-Palmolive has a 12-month low of $63.43 and a 12-month high of $77.27. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.92 and a current ratio of 1.23. The stock has a market capitalization of $64,312.43, a price-to-earnings ratio of 25.52, a PEG ratio of 3.35 and a beta of 0.81.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the company earned $0.73 EPS. The business’s revenue was up 2.8% compared to the same quarter last year. research analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This news story was first published by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another site, it was copied illegally and reposted in violation of U.S. & international copyright and trademark laws. The correct version of this news story can be read at https://www.watchlistnews.com/winslow-evans-crocker-inc-sells-1999-shares-of-colgate-palmolive-cl/1767423.html.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with Analyst Ratings Network's FREE daily email newsletter.